- Home
- MASI
MASI
Masimo Corporation
as 09-15-2025 4:00pm EST
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 8.1B | IPO Year: | 2007 |
| Target Price: | $194.60 | AVG Volume (30 days): | 609.4K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $111.03 - $194.88 | Next Earning Date: | 11-04-2025 |
| Revenue: | $2,153,800,000 | Revenue Growth: | 25.86% |
| Revenue Growth (this year): | -25.95% | Revenue Growth (next year): | 7.80% |
Stock Insider Trading Activity of Masimo Corporation (MASI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Brennan Michelle | MASI | N/A | Aug 13 '25 | Buy | $155.25 | 100 | $15,525.00 | 7,318 | |
| Brennan Michelle | MASI | N/A | Aug 12 '25 | Buy | $150.35 | 100 | $15,035.00 | 7,318 | |
| Jellison William R | MASI | N/A | Aug 11 '25 | Buy | $145.98 | 3,000 | $437,940.00 | 4,790 |
Latest Masimo Corporation News
MASI Breaking Stock News: Dive into MASI Ticker-Specific Updates for Smart Investing
MT Newswires
5 days ago
Philips, Masimo Renew Multi-Year Technology Partnership
Business Wire
5 days ago
Masimo Announces Expansion of Strategic Partnership with Philips
Insider Monkey
11 days ago
Apple Watch (AAPL) Blood Oxygen Feature Reintroduced in US After Legal Battle
Zacks
12 days ago
Is it the Right Time to Add CRL Stock to Your Portfolio Now?
StockStory
3 months ago
The 5 Most Interesting Analyst Questions From Masimo’s Q1 Earnings Call
StockStory
3 months ago
3 Unprofitable Stocks with Questionable Fundamentals
Argus Research
3 months ago
MASI: Raising target price to $176.00
Business Wire
3 months ago
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia
Compare MASI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MASI Masimo Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.